Kanayama, Naoyuki
Ikawa, Toshiki
Takano, Koji
Arita, Hideyuki
Morimoto, Masahiro
Hirata, Takero
Ogawa, Kazuhiko
Teshima, Teruki
Konishi, Koji
Funding for this research was provided by:
JSPS KAKENHI Grant (No. 21K15857)
Article History
Received: 23 January 2024
Accepted: 6 July 2024
First Online: 27 July 2024
Declarations
:
: This retrospective study was approved by the ethics committee of the Osaka International Cancer Institute (approval number: 21150).
: This study has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki). All patients signed informed consent for the use of their data for research purposes before starting fSRS.
: Naoyuki Kanayama received an honorarium from Varian Medical Systems as a HyperArc consultant. Toshiki Ikawa received an honorarium from Varian Medical Systems as a HyperArc consultant. Koji Takano: None. Hideyuki Arita: None. Masahiro Morimoto: None. Takero Hirata: None. Kazuhiko Ogawa: None. Teruki Teshima: None. Koji Konishi: None.